Yonhap Infomax NewsOct 27
Novartis AG will acquire US biotech firm Avidity Biosciences for $12 billion, paying a 46% premium, as part of its strategy to boost R&D and raise sales growth forecasts.
#YonhapInfomax #Novartis #AvidityBiosciences #Acquisition #RNATherapeutics #SalesGrowthForecast #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=87323
Novartis to Acquire US Biotech Firm for $12 Billion

Novartis AG will acquire US biotech firm Avidity Biosciences for $12 billion, paying a 46% premium, as part of its strategy to boost R&D and raise sales growth forecasts.

Yonhap Infomax